抗阻训练治疗慢性心力衰竭相关性肌少症的研究进展

doi:10.3969/j.issn.1006-9771.2017.07.013

摘要/Abstract

摘要： 肌少症是慢性心衰患者的常见并发症之一。慢性心衰相关性肌少症发病机制复杂。抗阻训练作为慢性心衰相关性肌少症的主要干预手段,干预效果已得到广泛认可,安全有效,适合临床推广。

Abstract: Sarcopenia is common in chronic heart failure. The pathogenesis of chronic heart failure-related sarcopenia is complex and diverse. Resistance training, as the main intervention for chronic heart failure-related sarcopenia, is widely applicated as effective and safe therapy.

Key words: chronic heart failure, sarcopenia, resistance training, rehabilitation, review

中图分类号:

R541.6

苏媛媛, 张伟宏, 宋晓月, 孙丹, 余珍, 潘利妞. 抗阻训练治疗慢性心力衰竭相关性肌少症的研究进展[J]. 《中国康复理论与实践》, 2017, 23(7): 799-801.

SU Yuan-yuan, ZHANG Wei-hong, SONG Xiao-yue, SUN Dan, YU Zhen, PAN Li-niu. Advances in Resistance Training for Chronic Heart Failure-related Sarcopenia (review)[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2017, 23(7): 799-801.

参考文献

[1] 陈伟伟,高润霖,刘力生,等. 中国心血管病报告2015概要[J]. 中国循环杂志, 2016, 31(6): 521-528.
[2] Collamati A, Marzetti E, Calvani R, et al. Sarcopenia in heart failure: mechanisms and therapeutic strategies [J]. J Geriatr Cardiol, 2016, 13(7): 615-624.
[3] Rosenberg IH. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons [J]. Am J Clin Nutr, 1989, 50: 1231-1233.
[4] Rosenberg IH. Sarcopenia: origins and clinical relevance [J]. J Nutr, 1997, 127(5): S990-S991.
[5] Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis; Report of the European Working Group on Sarcopenia in Older People [J]. Age Aging, 2010, 39(4): 412-423.
[6] Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia [J]. J Am Med Dir Assoc, 2011, 12(4): 249-256.
[7] Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia [J]. J Am Med Dir Assoc, 2014, 15(2): 95-101.
[8] 张冰,李维辛. 老年人糖尿病相关性肌少症的研究进展[J]. 中国康复理论与实践, 2016, 22(11): 1294-1297.
[9] Springer J, Anker MS, Anker SD, et al. Advances in cachexia and sarcopenia research in the heart failure context: call for action [J]. J Cardiovasc Med, 2016, 17(12): 860-862.
[10] Chang SF. Sarcopenia in the elderly: diagnosis and treatment [J]. Hu Li Za Zhi, 2014, 61(2): 101-105.
[11] Morley JE. Sarcopenia in the elderly [J]. Fam Pract, 2012, 29(Suppl): i44-i48.
[12] Bekfani T, Pellicori P, Morris DA, et al. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life [J]. Int J Cardiol, 2016, 222: 41-46.
[13] Fulster S, Tacke M, Sandek A, et al. Muscle wasting in patients with chronic heart failure: Results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF) [J]. Eur Heart J, 2013, 34(7): 512-519.
[14] Eiichi A, Masaaki K, Yasushi M, et al. Sarcopenia is associated with the severity of heart failure in patients with acute decompensated heart failure [J]. J Am Coll Cardiol, 2014, 63(12s): A545.
[15] Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure [J]. Circulation, 1992, 85(4): 1364-1373.
[16] Von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure [J]. Cardiovasc Res, 2007, 73(2): 298-309.
[17] Loncar G, Fulster S, von Haehling S, et al. Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure [J]. Int J Cardiol, 2013, 162(2): 77-85.
[18] Piepoli MF, Coats AJ. The "skeletal muscle hypothesis in heart failure" revised [J]. Eur Heart J, 2013, 34(7): 486-488.
[19] Strassburg S, Springer J, Anker SD. Muscle wasting in cardiac cachexia [J]. Int J Biochem Cell B, 2005, 37(10): 1938-1947.
[20] Anker SD, Swan JW, Volterrani M, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure [J]. Eur Heart J, 1997, 18(2): 259-269.
[21] Pureza V, Florea VG. Mechanisms for cachexia in heart failure [J]. Curr Heart Fail Rep, 2013, 10(4): 307-314.
[22] Taro N, Tetsu W, Shinpei K, et al. Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure [J]. Eur J Intern Med, 2015, 26(2): 118-122.
[23] 马跃文,刘畅. 心脏康复对于冠心病患者抑郁、焦虑情绪改善的研究进展[J]. 中国康复理论与实践, 2012, 18(2): 141-143.
[24] 李瑞洁,李宝寅,秦雷. 心脏康复综合管理对年轻冠心病PCI术后患者运动耐力的影响[J]. 中国现代药物应用, 2015, 9(5): 249-250.
[25] Arnold P, Bautmans I. The influence of strength training on muscle activation in elderly persons: a systematic review and meta-analysis [J]. Exp Gerontol, 2014, 58: 58-68.
[26] Demontis F, Piccirillo R, Goldberg AL, et al. The influence of skeletalmuscle on systemic aging and lifespan [J]. Aging Cell, 2013, 12(6): 943-949.
[27] Lenk K, Erbs S, Hoellriegel R, et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure [J]. Eur J Cardiovasc Prev Rehabil, 2012, 19(3): 404-411.
[28] Keteyian SJ, Pina IL, Hibner BA, et al. Clinical role of exercise training in the management of patients with chronic heart failure [J]. J Cardiopulm Rehabil Prey, 2010, 30(2): 67-76.
[29] Keteyian SJ. Exercise training in congestive heart failure: risks and benefits [J]. Prog Cardiovasc Dis, 2011, 53(6): 419-428.
[30] Garber CE, Blissmer B, Deschenes MR, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise [J]. Med Sci Sports Exerc, 2011, 43(7): 1334-1359.
[31] Hurley BF, Roth SM. Strength training in the elderly: effects on risk factors for age-related diseases [J]. Sports Med, 2000, 30(4): 249-268.
[32] Braith RW, Beck DT. Resistance exercise: training adaptations and developing a safe exercise prescription [J]. Heart Fail Rev, 2008, 13(1): 69-79.
[33] Strasser B, Keinrad M, Haber P, et al. Efficacy of systematic endurance and resistance on muscle strength and endurance performance in elderly adults–a randomized controlled trial [J]. Wien Klin Wochenschr, 2009, 121(23-24): 757-764.
[34] Carlson ME, Suetta C, Conboy MJ, et al. Molecular aging and rejuvenation of human muscle stem cells [J]. EMBO Mol Med, 2009, 1(8/9): 381-391.
[35] Robinson S, Cooper C, Aihie Sayer A. Nutrition and sarcopenia: a review of the evidence and implications for preventive strategies [J]. J Aging Res, 2012, 2012: 510801.
[36] 方磊,刘玉超. 增龄性骨骼肌减少症诊断与干预的研究现状[J]. 中国组织工程研究与临床康复, 2009, 13(2): 392-395.
[37] Feigenbaum MS, Pollock ML. Prescription of resistance training for health and disease [J]. Med Sci Sports Exec, 1999, 31(1): 38-45.
[38] Galvao DA, Taaffe DR, Spry N, et al. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial [J]. J Clin Oncol, 2010, 28(2): 340-347.
[39] Fiatarone MA, Marks EC, Ryan ND, et al. High-intensity strength training in nonagenarians: effects on skeletal muscle [J]. JAMA, 1990, 263(22): 3029-3034.
[40] Candow DG, Chilibeck PD, Abeysekara S, et al. Short term heavy resistance training eliminates age-related deficits in muscle mass and strengthin healthy older males [J]. J Strength Cond Res, 2011, 25(2): 326-333.
[41] Williams MA, Haskell WL, Ades PA, et al. Resistance exercise inindividuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Councilon Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism [J]. Circulation, 2007, 116(5): 572-584.